Jaro Education Q1FY27: standalone PAT +48% YoY to ₹11.2 Cr, OPM still short of 30% goal
PAT +48.3% YoY · revenue +16.6% · margins compressing
₹70.75 Cr
+16.6% YoY
₹11.17 Cr
+48.3% YoY
15.38%
+3pp YoY
₹5.11
Jaro Institute's standalone Q1 FY27 (quarter ended June 30, 2026) revenue from operations came in at ₹70.75 Cr, up 16.6% YoY from ₹60.67 Cr but down 2.8% QoQ from ₹72.79 Cr. Net profit was ₹11.17 Cr, up 48.3% YoY from ₹7.53 Cr, but down 47.6% QoQ from Q4 FY26's ₹21.33 Cr — the YoY print is the one that matters, and on that basis this is a clean growth-with-margin-expansion quarter, not the sequential slowdown the QoQ number implies. There were no exceptional items on either side, so the YoY PAT growth of 48.3% is the clean, comparable figure. NPM expanded to 15.79% from 12.39% a year ago, helped by finance costs falling to ₹0.16 Cr from ₹1.49 Cr (debt was prepaid using IPO proceeds). OPM, however, compressed to 21.43% from 23.00% YoY as employee costs (₹20.13 Cr vs ₹18.83 Cr) and other expenses (₹35.45 Cr vs ₹27.89 Cr) grew faster than revenue — both are still well short of the ~30% EBITDA-margin and ~20% PAT-margin "medium term" aims management flagged on the Q3 FY26 call, and revenue growth of 16.6% YoY trails the 20-25% annual growth band the same call guided to, so this quarter reads as on-track-but-not-yet-there against that guidance rather than a beat.
Q1 FY-2027 vs prior quarters
The QoQ decline is largely a seasonal and non-operating artefact: Q4 (Jan-Mar) is the education sector's peak admission quarter and also carried an unusually large ₹9.06 Cr other-income line versus ₹1.88 Cr this quarter, reflecting interest earned on unutilised IPO proceeds that have since been substantially deployed — of the ₹170 Cr raised, ₹30.04 Cr remains unutilised (₹28.70 Cr of it earmarked for marketing/brand-building), which explains both the lower interest income and the step-up in other expenses this quarter as that spend ramps. There is no press release in the record to cross-check management's own framing of the quarter, and no analyst consensus could be found for Q1 FY27, so street comparison is unknown. Corporate context this quarter includes the 17th AGM (July 28) and dividend record date (July 21) tied to the FY26 payout, a revised IPO-expense estimate approved July 4, and 91,696 shares allotted under ESOP schemes — none of which are large enough to move the P&L materially.
The stock went into the print at ₹458.2, down 12.7% over the past month of trading.
What the summary numbers don't show
Basic EPS ₹5.11 vs ₹3.70 YoY, vs ₹9.84 QoQ.
Management projects annual revenue growth of 20-25%, driven by new partnerships like J.K. Shah and program expansion. They aim to restore EBITDA margins to approximately 30% and PAT margins to around 20% in the medium term by improving operational leverage and increasing organic leads. While strategically focused on ex
— This quarter: missed
W1
Whether OPM/NPM re-expand toward management's ~30%/~20% medium-term targets as the low-Q1 seasonal base passes.
W2
Full-year revenue growth trajectory against the 20-25% FY27 guidance band — Q1 printed at 16.6% YoY, below it.
W3
Deployment pace of the remaining ₹30.04 Cr unutilised IPO proceeds (₹28.70 Cr marketing) and its effect on expense lines and growth.
Standalone only - Note 10 confirms no subsidiary/associate/JV so no consolidated statement is prepared; Q4 FY26 comparative is a balancing figure per Note 2; sequential PAT drop is mainly a normalisation of other income (Q4 carried a seasonal ₹9.06 Cr other-income spike vs ₹1.88 Cr this quarter) rather than an operating issue.